BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 192629)

  • 1. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N; Okamoto M; Tomoda Y
    Obstet Gynecol; 1973 Jul; 42(1):1-11. PubMed ID: 4352641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of chorioadenoma destruens from hydatidiform mole by urinary steroid analysis.
    Kodama M; Kodama T; Totani R
    Am J Obstet Gynecol; 1981 Oct; 141(3):288-93. PubMed ID: 6269431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid profiles in hydatidiform mole associated with theca-lutein cysts.
    Vanluchene E; Thiery M; Dhont M; Vandekerchkhove D
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):294-7. PubMed ID: 906612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; PĆ¼rstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vesicular mole with slight elimination of HCG in a clinical series from 1964 to the present].
    Cappelli N; Giorgi G; Teti G
    Minerva Ginecol; 1977 Nov; 29(11):802. PubMed ID: 609381
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the results of hydatidiform mole managed by Niigata method].
    Hando T; Kodama S; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the follow up period of postmolar patient (author's transl)].
    Hando T; Maruyama S; Watanabe S; Hirogami T; Obata N; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):287-91. PubMed ID: 7069243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY; Cole LA; Kardana A
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on follow-up procedure for postmolar patients].
    Endo N; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary hCG excretion patterns of patients with chorionic tumor during chemotherapy: indication of remission by chemotherapy].
    Isojima S; Koyama K; Kamata T; Naka O; Kushiki N
    Nihon Naibunpi Gakkai Zasshi; 1973 Dec; 49(12):1424-35. PubMed ID: 4359526
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.